Genital Herpes Market Outlook, Trends And Future Opportunities (2023-2030)

Download FREE Sample Customize As Per Need Buy Now
  1. home
  2. Report Store
  3. Genital Herpes Market

Genital Herpes Market Outlook, Trends And Future Opportunities (2023-2030)

Genital Herpes Market, By Type (HSV-1, HSV-2, Others (HSV-1/HSV-2)), By Drug Class (Nucleoside analogues, Non-nucleoside polymerase inhibitors, Helicase-primase inhibitors, Others), By Route of Administration (Oral, Topical, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

  • Published On: Oct 2023
  • Report ID: IDA49
  • Region: Global
  • Format: PDF/EXCEL
Press Release: Genital Herpes Market is Forecasted to Hit US$ 7.1 Bn By 2030 | CAGR 4.5%

Genital Herpes Market Segmentation:

  • By Type
    • HSV-1
    • HSV-2
    • Others (HSV-1/HSV-2)
  • By Drug Class
    • Nucleoside analogues
    • Non-nucleoside polymerase inhibitors
    • Helicase-primase inhibitors
    • Others
  • By Route of Administration
    • Oral
    • Topical
    • Injectable
    • Others
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Others
  • By Regions
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • Israel
      • South Africa
      • North Africa
      • Central Africa
      • Rest of the Middle East

Top companies in the Genital Herpes Market:

  • GlaxoSmithKline
  • Merck & Co.
  • Abbott
  • Becton, Dickinson and Company (BD)
  • Danaher
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Diasorin
  • Quidel
  • Siemens Healthineers
  • Hologic
  • Cepheid
  • Trinity Biotech
  • Abcam
  • BioMerieux
  • Teco Diagnostics
  • Abott Laboratories
  • Bundi International Diagnostics
  • Chrono-Log Corp
  • Corgenix

Frequently Asked Questions

The current market size of the genital herpes industry is estimated at around US$ 5.2 billion in 2023.

Rising prevalence of HSV infections globally, advances in novel antiviral drugs and vaccines, growing public awareness about STIs, increasing healthcare expenditure, and improved access to screening and diagnosis are some key factors driving genital herpes market growth.

Barriers to growth in the Genital Herpes Market include stigma, limited treatment options, and lack of awareness.

The leading component segment in the Genital Herpes Market is nucleoside analogues (acyclovir, valacyclovir etc) due to their high efficacy in managing outbreaks.

GlaxoSmithKline, Merck & Co., Abbott, Becton Dickinson and Company (BD), Danaher, Thermo Fisher Scientific, F. Hoffmann-La Roche.

The genital herpes market is expected to grow at a CAGR of 4.5% from 2023 to 2030. The market size is estimated to reach USD 7.1 billion by 2030.

Rising prevalence of HSV infections globally, Advances in novel antiviral drugs and vaccines, Growing public awareness about STIs.
Download FREE Sample Buy Now